☆ 4.6 Article

Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer

FRONTIERS IN GENETICS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Immunology

Immunogenic cell stress and death

Guido Kroemer et al.

Summary: Immunogenic cell death (ICD) plays an important role in therapy and disease, as dying mammalian cells release signals that interact with the host to determine the immunological correlates of cellular stress and death. ICD is crucial in immunosurveillance and is related to strategies evolved by pathogens and cancer cells. Additionally, normal cell death can also initiate antigen-specific immune responses.

NATURE IMMUNOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy

Bhalchandra Mirlekar

Summary: Cytokines, particularly interleukin-10, transforming growth factor-beta, interleukin-4, and interleukin-35, play a crucial role in regulating host immune response towards cancer and determining the fate of tumorigenesis by controlling effector antitumor immunity and promoting the survival and proliferation of cancer cells within the tumor microenvironment. Targeting these immune-suppressive cytokines may hold promise for developing more effective immune-therapeutic approaches in cancer treatment, despite challenges posed by the highly immune-suppressive tumor milieu.

SAGE OPEN MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors

Fotis Nikolos et al.

Summary: Chemoimmunotherapy has shown limited clinical benefit in bladder cancer patients and the reasons for this are not well understood. This study reveals that platinum-based chemotherapy hinders the infiltration and activity of CD8+ T cells in mouse models of muscle-invasive bladder cancer. The release of prostaglandin E-2 (PGE(2)) from dying cancer cells is identified as a mechanism that inhibits dendritic cell maturation. By blocking PGE(2) release, CD8+ T cells regain their tumoricidal activity and infiltrate the tumor site. Blocking PGE(2) release synergizes with chemotherapy and enhances the response to immune checkpoint inhibitor therapy. These findings highlight the potential of targeting the COX-2/PGE2 axis in chemoimmunotherapy for bladder cancer.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Review Urology & Nephrology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

J. Alfred Witjes et al.

Summary: This article presents the updated European Association of Urology guidelines for muscle-invasive and metastatic bladder cancer, providing practical evidence-based recommendations and consensus statements on clinical management. The guidelines cover a broad scope and incorporate the latest research findings and results from consensus meetings.

EUROPEAN UROLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Golnaz Morad et al.

Summary: This passage discusses the unprecedented advances in cancer treatment with immune checkpoint blockade (ICB), highlighting the critical need for insights into factors intrinsic and extrinsic to the host that impact ICB response and toxicity. There has been substantial progress in understanding the impact of host-intrinsic factors and the exposome on host physiology and response to treatment, representing the hallmarks of response, resistance, and toxicity to ICB in current day.

CELL (2021)

添加到收藏夹

Article Cell Biology

Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer

Bianca Oresta et al.

Summary: The study revealed the mechanism by which Mitomycin C promotes immunogenic cell death, relying on metabolic reprogramming of tumor cells towards increased oxidative phosphorylation. This finding offers opportunities to optimize bladder cancer management and provides potential markers of treatment efficacy.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Review Oncology

Heterogeneous Myeloid Cells in Tumors

Aixia Dou et al.

Summary: Myeloid cells play a crucial role in tumor development, with pro-tumor and anti-tumor functions that impact tumor cells, tumor microenvironment, and immune system.

CANCERS (2021)

添加到收藏夹

Article Cell Biology

Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis

Jun-Lin Lu et al.

Summary: The study found that TLR4 expression is decreased in tumor tissues compared to surrounding tissues or normal tissue, and is positively correlated to the overall survival rate and cancer-specific survival rate of bladder cancer patients. Low TLR4 expression is associated with malignant performance in tumors.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Genetics & Heredity

Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer

Ke Zhu et al.

Summary: A prognostic signature was constructed to predict the outcome of BLCA, and the mechanisms of UPR in BLCA were further investigated. This signature was closely related to immune checkpoints and immune cells infiltration, helping to distinguish low-risk groups from high-risk groups.

HUMAN GENOMICS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Inflammation and tumor progression: signaling pathways and targeted intervention

Huakan Zhao et al.

Summary: Inflammation plays a crucial role in cancer development and therapy, either promoting or inhibiting tumor progression and therapeutic outcomes. Various signaling pathways and factors have been identified as pivotal regulators of inflammation initiation and resolution.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Review Cell Biology

Calreticulin and cancer

Jitka Fucikova et al.

Summary: CALR is a protein located in the endoplasmic reticulum that plays important roles in cellular processes and protein folding. It acts as a chaperone in healthy cells, assisting protein folding and supporting Ca2+-dependent processes, while also being exposed on the cell surface in cancer cells to promote immunogenic cell death. Loss-of-functionCALRmutations can promote oncogenesis by impairing cellular homeostasis and compromising natural and therapy-driven immunosurveillance.

CELL RESEARCH (2021)

添加到收藏夹

Article Urology & Nephrology

Clinical outcome after progressing to frontline and second-line Anti-PD-1/PD-L1 in advanced urothelial cancer

Alfonso Gomez de Liano Lista et al.

EUROPEAN UROLOGY (2020)

添加到收藏夹

Review Immunology

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment

Maria Esperanza Rodriguez-Ruiz et al.

NATURE IMMUNOLOGY (2020)

添加到收藏夹

Review Oncology

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment

Aleksei Titov et al.

CANCERS (2020)

添加到收藏夹

Review Oncology

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Lorenzo Galluzzi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Article Cell Biology

Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis

Lingyun Liu et al.

AGING-US (2020)

添加到收藏夹

Review Cell Biology

Detection of immunogenic cell death and its relevance for cancer therapy

Jitka Fucikova et al.

CELL DEATH & DISEASE (2020)

添加到收藏夹

Article Oncology

eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer

Shruthy Suresh et al.

NATURE CANCER (2020)

添加到收藏夹

Article Urology & Nephrology

Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer

Emily Feld et al.

EUROPEAN UROLOGY (2019)

添加到收藏夹

Article Oncology

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Lenka Kasikova et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

Fangyuan Zhou et al.

ADVANCED MATERIALS (2019)

添加到收藏夹

Review Urology & Nephrology

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Sebastien Antoni et al.

EUROPEAN UROLOGY (2017)

添加到收藏夹

Review Oncology

Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer

Heather Katz et al.

MEDICAL ONCOLOGY (2017)

添加到收藏夹

Editorial Material Multidisciplinary Sciences

UNLOCKING BLADDER CANCER

Chris Berdik

NATURE (2017)

添加到收藏夹

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

添加到收藏夹

Review Immunology

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth et al.

NATURE REVIEWS IMMUNOLOGY (2017)

添加到收藏夹

Article Medicine, Research & Experimental

Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion

Jacob S. Bowers et al.

JCI INSIGHT (2017)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Functional Roles of Calreticulin in Cancer Biology

Yi-Chien Lu et al.

BIOMED RESEARCH INTERNATIONAL (2015)

添加到收藏夹

Article Multidisciplinary Sciences

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Thomas Powles et al.

NATURE (2014)

添加到收藏夹

Article Oncology

Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis

Firas Abdollah et al.

CANCER EPIDEMIOLOGY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

SJ Gardai et al.

CELL (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.